Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer
Study Number: 

PH 253914

Phase: 
Early Phase
Principal Investigator: